Chad Swanson

The potential of lecanemab for the treatment of early Alzheimer’s disease 1:38
The potential of lecanemab for the treatment of early Alzheimer’s disease
Chad Swanson • 13 Aug 2021
Lecanemab for the treatment of early Alzheimer’s disease: the story so far 2:02
Lecanemab for the treatment of early Alzheimer’s disease: the story so far
Chad Swanson • 13 Aug 2021
Lecanemab: Phase II open-label extension results 4:59
Lecanemab: Phase II open-label extension results
Chad Swanson • 13 Aug 2021
Phase III AHEAD 3-45 trial of lecanemab for preclinical Alzheimer’s disease 1:57
Phase III AHEAD 3-45 trial of lecanemab for preclinical Alzheimer’s disease
Chad Swanson • 13 Aug 2021
The content of VJDementia is intended for healthcare professionals